MUDr. Zakova s.r.o.
- Address
- Suvoz 1, Kubra, 911 01 Trenčín, Slovakia
Cardiovascular Research
The site advances knowledge in cardiovascular diseases, targeting conditions that drive heart attacks and stroke.
- Atherosclerotic cardiovascular disease
- Chronic kidney disease linked to heart risk
- Type 2 diabetes with elevated LDL‑C
- Strategies to lower major cardiovascular events
Studies evaluate new oral agents and combination therapies aimed at reducing LDL‑C and preventing heart complications, offering hope for patients with high cardiovascular risk.
Digestive System Research
Investigations focus on digestive system diseases, especially how antibiotics affect the gut environment.
- Probiotic Saccharomyces boulardii and gut microbiota balance
- Microbiome changes during treatment of early Lyme disease
- Interaction of antibiotics with intestinal health
The trials aim to improve patient outcomes by understanding and modulating the gut microbiota during antibiotic therapy, potentially reducing side effects and infection recurrence.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Biocodex1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in MUDr. Zakova s.r.o.
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Effect of Orforglipron on Major Adverse Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease | Eli Lilly & Co. | Phase III | Recruiting | May 2026 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amoxicillin | 1 | Unknown | 2024-06-18 | 2024-06-18 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.